LTA
Summary: The encoded protein, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis. Genetic variations in this gene are associated with susceptibility to leprosy type 4, myocardial infarction, non-Hodgkin's lymphoma, and psoriatic arthritis. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| lymphotoxin alpha | MIM:153440 | Ensembl:ENSG00000226979 | HGNC:HGNC:6709 | PA30474 | 6p21.33 |
GO terms in LTA
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | TAS | GO:0005102 | signaling receptor binding |
| MF | IEA | GO:0005125 | cytokine activity |
| MF | IEA | GO:0005164 | tumor necrosis factor receptor binding |
| MF | IPI | GO:0005515 | protein binding |
| BP | IEA | GO:0001666 | response to hypoxia |
| BP | IEA | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus |
| BP | IEA | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| BP | TAS | GO:0006915 | apoptotic process |
| BP | IEA | GO:0006959 | humoral immune response |
| BP | TAS | GO:0007165 | signal transduction |
| BP | TAS | GO:0007267 | cell-cell signaling |
| BP | IEA | GO:0007584 | response to nutrient |
| BP | IEA | GO:0010469 | regulation of signaling receptor activity |
| BP | IEA | GO:0032496 | response to lipopolysaccharide |
| BP | IEA | GO:0032729 | positive regulation of interferon-gamma production |
| BP | TAS | GO:0033209 | tumor necrosis factor-mediated signaling pathway |
| BP | IEA | GO:0042493 | response to drug |
| BP | IEA | GO:0043065 | positive regulation of apoptotic process |
| BP | IEA | GO:0044130 | negative regulation of growth of symbiont in host |
| BP | IEA | GO:0048147 | negative regulation of fibroblast proliferation |
| BP | IEA | GO:0048535 | lymph node development |
| BP | IEA | GO:0050830 | defense response to Gram-positive bacterium |
| BP | IEA | GO:0060252 | positive regulation of glial cell proliferation |
| CC | IEA | GO:0005615 | extracellular space |
| CC | TAS | GO:0005886 | plasma membrane |
Gene expression in normal tissue: LTA
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LTA
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
| reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway |
| reactome | R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway |
| reactome | R-HSA-5669034 | TNFs bind their physiological receptors |
| reactome | R-HSA-5676594 | TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway |
| reactome | R-HSA-5676594 | TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway |
| biocarta | tnfr2pathway | tnfr2 signaling pathway |
| pid | il2_stat5pathway | IL2 signaling events mediated by STAT5 |
| pid | il4_2pathway | IL4-mediated signaling events |
| kegg | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) |
| kegg | hsa04064 | NF-kappa B signaling pathway - Homo sapiens (human) |
| kegg | hsa04668 | TNF signaling pathway - Homo sapiens (human) |
| kegg | hsa04940 | Type I diabetes mellitus - Homo sapiens (human) |
| kegg | hsa05166 | HTLV-I infection - Homo sapiens (human) |
| kegg | hsa05168 | Herpes simplex infection - Homo sapiens (human) |
| wikipathways | WP254 | Apoptosis |
| wikipathways | WP3639 | Apoptotic Signaling Pathway |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in LTA

